ArrayExpress Uploader0432922.022.880nanOesophagusM-0.943.5667.4172.0cancer1.025.682nanOesophagusM-3.893.7477.6174.0cancer14.029.8747101.0OesophagusM4.262.8586.0170.0cancer1.029.8612949.0OesophagusM-6.443.2889.1173.0cancer1.020.1584251.0GastricM-1.263.7259.5172.0cancer6.027.15612224.0OesophagusM-0.723.9681.9174.0cancer28.032.9703116.0pancreasM-3.482.06105.5179.0cancer36.020.5596015.0pancreasF-25.033.0256.4166.0cancer1.030.559nanpancreasM-23.383.8192.4174.0cancer1.031.667nanpancreasM-10.144.2391.3170.0cancer1.022.0605716.0GastricM-1.215.8759.6165.0cancer5.023.4633489.0OesophagusF-16.251.9371.8175.0cancer22.021.880nanOesophagusM-0.944.2964.6172.0cancer-free1.020.782nanOesophagusM-3.893.3462.6174.0cancer-free14.027.7746269.0OesophagusM4.263.0180.1170.0cancer-free1.024.5613490.0OesophagusM-6.443.9373.2173.0cancer-free1.019.7586686.0GastricM-1.263.758.2172.0cancer-free6.023.5565933.0OesophagusM-0.7213.4271.0174.0cancer-free28.031.5705020.0pancreasM-3.482.48101.0179.0cancer-free36.020.3596292.0pancreasF-25.033.3756.0166.0cancer-free1.029.059nanpancreasM-23.382.887.7174.0cancer-free1.033.067nanpancreasM-10.145.095.4170.0cancer-free1.020.4608420.0GastricM-1.215.8955.3165.0cancer-free5.022.5633295.0OesophagusF-16.253.2368.8175.0cancer-freenan26.551nanHCMnot specifiednan87.4184.5healthy controlnan22.777nanHCFnot specifiednan64.0168.0healthy controlnan26.742nanHCFnot specifiednan65.0156.0healthy controlnan27.166nanHCMnot specifiednan86.0178.0healthy control2.033.566nanHCMnot specifiednan100.2173.0healthy controlnan33.048nanHCMnot specifiednan107.0180.0healthy controlarrayexpress_sid4The mechanisms underlying muscle wasting in cancer patients remain poorly understood, and consequently there remains an unmet clinical...22452944E-GEOD-34111/profile/8773/arrayexpressuploader1130cancerdiseasemusclemuscle wastingDec.12, 2014Falsegene-expression-in-skeletal-muscle-of-cancer-patieE-GEOD-34111_A-AFFY-44Gene expression in skeletal muscle of cancer patients before and after potentially curative surgerySep.16, 2014The mechanisms underlying muscle wasting in cancer patients remain poorly understood, and consequently there remains an unmet clinical need for new biomarkers and treatment strategies. Microarrays were used to examine the transcriptome in single biopsies from healthy controls (n=6) and in paired biopsies [pre-resection baseline (weight-loss 7%) and 8 month post-resection follow-up (disease-free /weight-stable for previous 2 months)] from quadriceps muscle of patients with upper gastrointestinal cancer (UGIC) (n=12).http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34111humanhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34111/samples/